The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation.

Saved in:
Bibliographic Details
Title: The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation.
Authors: Macchia A; Fundación Grupo de Estudio en Investigación Clínica en Argentina, Buenos Aires, Argentina. macchia@negrisud.it, Varini S, Grancelli H, Nul D, Laffaye N, Ferrante D, Tognoni G, Doval HC
Corporate Authors: FORomegaARD investigators
Source: American heart journal [Am Heart J] 2009 Mar; Vol. 157 (3), pp. 423-7. Date of Electronic Publication: 2009 Jan 08.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6744
DOI:10.1016/j.ahj.2008.10.027